Westlake Chemical Partners LP (WLKP)
:WLKP
US Market
Advertisement

Westlake Chemical PRN (WLKP) AI Stock Analysis

Compare
279 Followers

Top Page

WLKP

Westlake Chemical PRN

(NYSE:WLKP)

Select Model
Select Model
Select Model
Neutral 67 (OpenAI - 4o)
Rating:67Neutral
Price Target:
$20.50
▲(2.19% Upside)
Westlake Chemical PRN's strong valuation and solid financial performance are offset by bearish technical indicators and operational pressures highlighted in the earnings call. The high dividend yield is a significant positive, but the stock's current bearish trend and global economic challenges present risks.

Westlake Chemical PRN (WLKP) vs. SPDR S&P 500 ETF (SPY)

Westlake Chemical PRN Business Overview & Revenue Model

Company DescriptionWestlake Chemical Partners LP acquires, develops, and operates ethylene production facilities and related assets in the United States. The company's ethylene production facilities primarily convert ethane into ethylene. It also sells ethylene co-products, including propylene, crude butadiene, pyrolysis gasoline, and hydrogen directly to third parties on either a spot or contract basis. Westlake Chemical Partners GP LLC serves as the general partner of the company. The company was incorporated in 2014 and is headquartered in Houston, Texas.
How the Company Makes MoneyWestlake Chemical PRN generates revenue primarily through the production and sale of ethylene and polyethylene products. Its revenue model is based on the volume of products sold, with pricing influenced by market demand and raw material costs. The company also derives income from its ownership interest in Westlake's ethylene production facilities, receiving a portion of the profits generated from these operations. Significant partnerships with distributors and manufacturers in various industries further enhance its revenue streams. Additionally, the company's strategic focus on cost management and operational efficiency contributes to its profitability.

Westlake Chemical PRN Earnings Call Summary

Earnings Call Date:Oct 30, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 24, 2026
Earnings Call Sentiment Neutral
The earnings call reflected a stable business model with strong contractual agreements and a solid financial foundation. However, the lower net income and cash flow due to planned maintenance activities and global economic challenges indicate some current operational pressures.
Q3-2025 Updates
Positive Updates
Renewal of Ethylene Sales Agreement
OpCo and Westlake agreed to renew the Ethylene Sales Agreement through the end of 2027 with no changes to the contract terms or conditions, maintaining the same pricing formula and sales volume protections.
Stable Financial Performance
The Partnership's predictable fee-based cash flow continues to prove beneficial, with 45 consecutive quarterly distributions since its IPO in 2014, growing distributions by 71% since the original minimum distribution.
Strong Balance Sheet
Westlake Partners maintains conservative financial and leverage metrics, with a consolidated leverage ratio of approximately 1x and a stable cash position of $51 million.
Negative Updates
Decrease in Net Income and Distributable Cash Flow
Third quarter 2025 net income of $15 million was lower than the third quarter 2024 due to lower margins on ethylene sales and higher maintenance capital expenditures.
Impact of Planned Turnaround on Cash Flow
The planned turnaround at the Petro 1 ethylene unit resulted in lower production and sales, affecting the distributable cash flow coverage ratio.
Global Economic Challenges
The global industrial and manufacturing activity remains soft, impacting the global chemical industry.
Company Guidance
During the Westlake Chemical Partners Third Quarter 2025 Earnings Conference Call, management provided detailed financial metrics and guidance. The Partnership reported a net income of $15 million or $0.42 per unit, while the consolidated net income, including OpCo's earnings, was $86 million on $309 million in consolidated net sales. Distributable cash flow for the quarter was also $15 million or $0.42 per unit, which marked a $3 million decrease from the prior year due to higher maintenance capital expenditures. Despite these challenges, the Partnership maintained a strong leverage ratio of approximately 1x and announced a quarterly distribution of $0.4714 per unit, marking 45 consecutive quarterly distributions since its IPO. Looking ahead, Westlake Chemical Partners plans to leverage its Ethylene Sales Agreement, renewed through the end of 2027, to ensure stable and predictable cash flows despite global economic challenges. Additionally, the Partnership sees potential growth in increasing its ownership interest in OpCo, seeking qualified income stream acquisitions, expanding ethylene facilities, and possibly negotiating higher margins in its Ethylene Sales Agreement.

Westlake Chemical PRN Financial Statement Overview

Summary
Westlake Chemical PRN demonstrates solid financial health with strong profitability and operational efficiency. The income statement reflects stable margins and improving net income, while the balance sheet shows a balanced leverage position. Cash flow generation is strong, though recent declines in free cash flow warrant attention.
Income Statement
75
Positive
Westlake Chemical PRN shows a stable revenue base with a slight growth in TTM. The gross profit margin is healthy at 30.8%, and the net profit margin improved to 10.6% in TTM, indicating efficient cost management. However, the revenue growth rate has been inconsistent, with a recent TTM growth of 2.9% following a decline in previous years. The EBIT and EBITDA margins are strong, reflecting operational efficiency.
Balance Sheet
70
Positive
The company maintains a moderate debt-to-equity ratio of 0.79, indicating a balanced approach to leverage. The return on equity is robust at 23.7% in TTM, showcasing effective use of equity to generate profits. However, the equity ratio is relatively low, suggesting a higher reliance on debt financing.
Cash Flow
65
Positive
Operating cash flow remains strong with a high coverage ratio of 5.31 in TTM, indicating good cash generation relative to net income. However, free cash flow has declined by 14.3% in TTM, which could be a concern if the trend continues. The free cash flow to net income ratio is solid at 0.71, suggesting efficient cash conversion.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.13B1.14B1.19B1.59B1.21B966.67M
Gross Profit349.62M418.94M387.46M377.37M441.71M378.88M
EBITDA388.88M507.59M472.14M470.33M519.56M456.88M
Net Income49.16M62.39M54.28M64.17M82.55M66.17M
Balance Sheet
Total Assets1.27B1.29B1.32B1.37B1.48B1.36B
Cash, Cash Equivalents and Short-Term Investments37.94M58.32M58.62M64.78M17.06M17.15M
Total Debt399.67M399.67M399.67M399.67M399.67M399.67M
Total Liabilities458.30M458.64M460.59M468.27M508.00M441.35M
Stockholders Equity503.18M518.70M522.51M534.50M536.55M519.97M
Cash Flow
Free Cash Flow209.10M436.03M405.18M409.62M327.27M336.43M
Operating Cash Flow292.56M485.00M452.00M463.74M408.44M373.40M
Investing Cash Flow11.54M-88.97M-75.94M-12.00M-64.30M2.03M
Financing Cash Flow-326.37M-396.33M-382.23M-404.01M-344.24M-378.20M

Westlake Chemical PRN Technical Analysis

Technical Analysis Sentiment
Negative
Last Price20.06
Price Trends
50DMA
19.77
Negative
100DMA
20.52
Negative
200DMA
21.13
Negative
Market Momentum
MACD
-0.42
Negative
RSI
35.08
Neutral
STOCH
37.24
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For WLKP, the sentiment is Negative. The current price of 20.06 is above the 20-day moving average (MA) of 18.61, above the 50-day MA of 19.77, and below the 200-day MA of 21.13, indicating a bearish trend. The MACD of -0.42 indicates Negative momentum. The RSI at 35.08 is Neutral, neither overbought nor oversold. The STOCH value of 37.24 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for WLKP.

Westlake Chemical PRN Risk Analysis

Westlake Chemical PRN disclosed 2 risk factors in its most recent earnings report. Westlake Chemical PRN reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Westlake Chemical PRN Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
67
Neutral
$653.46M13.299.61%10.17%-0.82%-20.35%
64
Neutral
$587.07M-769.81-0.13%12.49%95.48%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
53
Neutral
$422.03M8.176.62%4.44%-5.05%35.01%
47
Neutral
$1.20B-10.68%36.31%
45
Neutral
$389.97M-78.11%-9.75%-386.63%
43
Neutral
$534.32M-18.65%11.22%-7.81%-334.15%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
WLKP
Westlake Chemical PRN
17.92
-2.78
-13.43%
BAK
Braskem SA
3.02
-2.08
-40.78%
LXU
Lsb Industries
9.29
0.81
9.55%
TROX
TRONOX
3.12
-7.21
-69.80%
RYAM
Rayonier Advanced Materials
5.52
-3.63
-39.67%
ASIX
AdvanSix
14.42
-14.66
-50.41%

Westlake Chemical PRN Corporate Events

Westlake Chemical Partners LP: Earnings Call Insights
Nov 1, 2025

Westlake Chemical Partners LP recently held its earnings call, revealing a stable yet pressured financial outlook. The company demonstrated resilience through strong contractual agreements and a solid financial foundation, despite facing operational challenges due to planned maintenance activities and global economic pressures.

Business Operations and StrategyFinancial Disclosures
Westlake Chemical PRN Renews Key Agreements for Stability
Neutral
Oct 30, 2025

On October 28, 2025, Westlake Chemical OpCo LP and Westlake Corporation renewed their Ethylene Sales Agreement and Feedstock Supply Agreement through December 31, 2027, ensuring stable and predictable cash flows for the Partnership. The renewal aligns with the Services and Secondment Agreement and includes amendments to the Omnibus Agreement, which addresses procedural requirements for Westlake’s indemnification obligations. The Partnership reported a decrease in third quarter 2025 net income and cash flows compared to 2024, primarily due to higher maintenance capital expenditures, but maintained a stable cash flow structure through its Ethylene Sales Agreement with Westlake.

The most recent analyst rating on (WLKP) stock is a Hold with a $21.00 price target. To see the full list of analyst forecasts on Westlake Chemical PRN stock, see the WLKP Stock Forecast page.

Westlake Chemical Partners LP: Stable Earnings Amid Global Challenges
Aug 6, 2025

The recent earnings call for Westlake Chemical Partners LP highlighted a stable financial performance amidst a challenging global environment. The sentiment was generally positive, with successful operational achievements such as the completion of the Petro 1 turnaround and consistent distributions. However, there were concerns regarding decreased distributable cash flow and a soft global industrial environment.

Business Operations and StrategyDividendsFinancial Disclosures
Westlake Chemical PRN Reports Steady Q2 2025 Income
Neutral
Aug 5, 2025

Westlake Chemical Partners LP reported a net income of $14.6 million for the second quarter of 2025, consistent with the previous year’s results, despite a significant decrease in cash flows from operating activities due to higher maintenance capital expenditures from the Petro 1 turnaround. The company announced its 44th consecutive quarterly distribution and expects improvement in distributable cash flow and coverage ratio in the second half of 2025, following the completion of the Petro 1 turnaround.

The most recent analyst rating on (WLKP) stock is a Buy with a $26.00 price target. To see the full list of analyst forecasts on Westlake Chemical PRN stock, see the WLKP Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 04, 2025